In our study, multiplatform data from The Cancer Genome Atlas (TCGA) were acquired to identify two subtypes of lung adenocarcinoma harboring KEAP1/NFE2L2 mutations. The gene discussed is NFE2L2; the disease is lung adenocarcinoma.